Skip to content
Search

Latest Stories

Nuffield Trust and The King’s Fund seek views on proposed ‘Future of community pharmacy’ vision

Nuffield Trust and The King’s Fund are seeking feedback from community pharmacy on their proposals for the future of community pharmacy and they are seeking feedback from community pharmacy stakeholders.

The online survey is the latest opportunity for pharmacy owners, LPCs and others in the sector to engage with the project to develop a Vision for Community Pharmacy.


Nuffield Trust and The King’s Fund want to hear their views on their proposals, ahead of the publication of the final report later this year. The vision is critically important, as it will be used to develop the future strategy for the sector and lay the groundwork for the next Community Pharmacy Contractual Framework (CPCF) negotiations.

The survey is asking for thoughts on key aspects of the vision and its recommendations. The vision has been developed by Nuffield Trust and The King’s Fund following an extensive programme of research, interviews and meetings of the vision Steering Group, Advisory Panel, and Working Groups, all of which have contractors, LPCs and other representatives of the sector at their heart.

The vision project team are looking forward to hearing views from across the sector on their proposals and what will need to happen to make them a reality.

The deadline for responses is 11.59pm on Monday (14 August).

In addition to the survey, the Community Pharmacy England is hosting an online engagement event with Nuffield Trust and The King’s Fund on Tuesday (25 July) at 7pm. This will allow any pharmacy owners to hear more from the authors of the report and to discuss their proposals.

This important project was commissioned by Community Pharmacy England to work towards a better future, laying the ground for the next Community Pharmacy Contractual Framework (CPCF) negotiations which will be critical for the future of all community pharmacies.

Commenting on the launch of the latest vision engagement exercise, Community Pharmacy England Chief Executive Janet Morrison said: “As community pharmacy owners and their teams work tirelessly in the face of a relentless workload and financial pressures, a chink of light in the shape of a £645m investment in service development has appeared. We need to build on that momentum as we edge ever closer to the end of the five-year CPCF.

“Having commissioned Nuffield Trust and The King’s Fund to develop a Vision for Community Pharmacy last year, we are eager to see what the sector makes of their proposals and implementation ideas. We need pharmacy owners and LPCs to check the recommendations and tell the project team what works and, more importantly, what doesn’t.

“This vision is critical for the future direction of the sector, so it’s apt that we are launching this final call for feedback at such an important time for healthcare. What we need now is views from the full breadth of community pharmacy so Nuffield Trust and The King’s Fund can finalise their recommendations, and we can take this forward with the backing of the whole sector. Only you can help make that vision a reality.”

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less